BRISTOL-MYERS SQUIBB COMPANY (BMY) Financial Analysis — Fisclear

Valuation

Pharmaceutical Preparations

Live · Yahoo Finance

Price

$63.64

52-Week Range

$42.52$63.64 now$68.64

Decision Context

Altman Z-Score indicates financial distress risk. Review debt levels and cash runway before any position sizing decision.

Based on filing period ending Jun 2026

FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.

BMY vs

Macro Context

Fed Funds Rate

3.63%

Accommodative

10-Year Treasury

4.47%

2026-06-01

Unemployment

4.2%

Near full employment

CPI Index

332.6

2026-06-01

M2 Money Supply

$23.2T

2026-06-01

The Federal Funds rate stands at 3.63% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 4.47%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 102.6; M2 money supply is $23.2T; CPI index stands at 332.6.

SWOT Analysis — BMY

Inflationary Boom

Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.

✦

Strengths

Net Income: $7.1B (+178.8% YoY) — Profit grew 179% — the company kept more of each dollar earned.
EPS (Diluted): $3.46 (+178.5% YoY) — Earnings per share rose 178% — each share earned more.
Gross Profit: $30.7B (+70.2% YoY) — Gross profit rose 70% — the spread between revenue and direct costs improved.

◈

Weaknesses

Operating Cash Flow: $14.2B (-6.8% YoY) — Operating cash flow fell 7% but remained positive.
Total Assets: $90.0B (-2.8% YoY) — Total assets shrank 3% — the balance sheet contracted.
Stock is near its 52-week high (65.66) — the price reflects strong recent momentum, but entry risk is elevated at these levels.

◎

Opportunities

No clear opportunities identified at this time.

⚠

Threats

Total liabilities represent 79% of total assets — elevated leverage that amplifies both gains and losses.

Financial Charts

Revenue vs Net Income

Gross Profit vs Operating Income

Margin Trend

Operating Cash Flow

Year-over-Year Changes

Net Income

$7.1B

was -$8.9B

+178.8%

Profit grew 179% — the company kept more of each dollar earned.

EPS (Diluted)

$3.46

was $-4.41

+178.5%

Earnings per share rose 178% — each share earned more.

Gross Profit

$30.7B

was $18.1B

+70.2%

Gross profit rose 70% — the spread between revenue and direct costs improved.

Operating Cash Flow

$14.2B

was $15.2B

−6.8%

Operating cash flow fell 7% but remained positive.

Total Assets

$90.0B

was $92.6B

−2.8%

Total assets shrank 3% — the balance sheet contracted.

Risk Flags

0 high · 1 medium · 1 low

◈ Medium
Total liabilities represent 79% of total assets — elevated leverage that amplifies both gains and losses.
○ Low
Stock is near its 52-week high (65.66) — the price reflects strong recent momentum, but entry risk is elevated at these levels.